Extended release Quetiapine Fumarate (Quetiapine XR) in acute and maintenance studies in Major Depressive Disorder (MDD): suicidality data

被引：0
|
作者：
Weisler, R. [1 ]
Montgomery, S. A. [2 ]
Eriksson, H. A. [3 ]
Szamosi, J. [3 ]
机构：
[1] Duke Univ, Med Ctr, Univ N Carolina Chapel Hill, Durham, NC USA
[2] Univ London, Imperial Coll Sch Med, London, England
[3] AstraZeneca R&D, Sodertalje, Sweden
来源：
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE | 2009年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
下载
收藏
页码：45 / 46
页数：2
相关论文
共 50 条
  • [21] EXTENDED RELEASE QUETIAPINE FUMARATE (QUETIAPINE XR) IN PATIENTS WITH MDD: RESULTS FROM 8 PLACEBO-CONTROLLED STUDIES
    Montgomery, S.
    Kalali, A.
    Earley, W.
    Szamosi, J.
    Eriksson, H.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [22] Double-blind study of once-daily extended release quetiapine fumarate (quetiapine XR) as monotherapy for major depressive disorder
    Weisler, R.
    Joyce, M.
    McGill, L.
    Lazarus, A.
    Schollin, M.
    Brecher, M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 186 - 186
  • [23] Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: A placebo-controlled, randomized study
    Bortnick, Brian
    El-Khalili, Nizar
    Banov, Michael
    Adson, David
    Datto, Catherine
    Raines, Shane
    Earley, Willie
    Eriksson, Hans
    JOURNAL OF AFFECTIVE DISORDERS, 2011, 128 (1-2) : 83 - 94
  • [24] Once-daily extended release quetiapine fumarate (quetiapine XR) as adjunct to) antidepressant therapy fit patients with major depressive disorder
    Constant, E.
    Pretorius, H. W.
    Earley, W.
    Lindgren, P.
    Brecher, M.
    Bauer, M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 184 - 184
  • [25] EVALUATION OF POTENTIAL PREDICTORS OF RESPONSE TO TREATMENT WITH ADJUNCT EXTENDED RELEASE QUETIAPINE FUMARATE (QUETIAPINE XR) IN PATIENTS WITH MDD
    Bauer, M.
    Thase, M.
    Liu, S.
    Earley, W.
    Eriksson, H.
    EUROPEAN PSYCHIATRY, 2012, 27
  • [26] A Randomized, Double-blind Study of the Efficacy and Tolerability of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Patients with Major Depressive Disorder
    Wang, Gang
    McIntyre, Alexander
    Earley, Willie R.
    Raines, Shane
    Eriksson, Hans
    PSYCHOPHARMACOLOGY BULLETIN, 2012, 45 (01) : 5 - 30
  • [27] Effects of once-daily extended release quetiapine fumarate (quetiapine XR) on quality of life and sleep in elderly patients with major depressive disorder
    Locklear, Julie C.
    Svedsater, Henrik
    Datto, Catherine
    Endicott, Jean
    JOURNAL OF AFFECTIVE DISORDERS, 2013, 149 (1-3) : 189 - 195
  • [28] Impact of methodology on the efficacy of extended release quetiapine fumarate in major depressive disorder
    Montgomery, S.
    Kalali, A.
    McIntyre, R. S.
    Earley, W. R.
    Nyberg, S.
    Eriksson, H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S353 - S353
  • [29] Efficacy of once-daily extended release quetiapine fumarate (quetiapine XR) in elderly patients with major depressive disorder (MDD) according to baseline anxiety symptoms, sleep disturbance and pain levels
    Montgomery, S.
    Altamura, A. C.
    Katila, H.
    Datto, C.
    Szamosi, J.
    Eriksson, H.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2011, 15 : 32 - 33
  • [30] A randomized, double-blind study of the efficacy and tolerability of extended-release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder
    Wang, Gang
    McIntyre, Alexander
    Earley, Willie R.
    Raines, Shane R.
    Eriksson, Hans
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2014, 10 : 201 - 216
12345